BLS vs IDX

ASX Healthcare sector comparison — updated 23 Jul 2026 — Healthcare sector

BLS

BLSPHARMA FPO [BLS]

56MEDIUM

IDX

INTEG DIAG FPO [IDX]

51MEDIUM

Score Breakdown

BLS IDX
Technical
49
45
Catalyst
55
53
Sentiment
50
50
Fundamental
96
100
Momentum
84
46
Risk Gate
50
34

Key Metrics

BLS Metric IDX
$193.2MMarket Cap$768.5M
218KAvg Volume (20d)683K
+0.0%Short Interest+1.4%
$1.10052-Week High$3.070
$0.33052-Week Low$1.905
+1.8%Daily Change-0.5%
$0.855Reference Price$2.060
+66.1%ROE+2.1%
+18.7%Profit Margin+1.8%

Active Signals

BLS Signals

●MACD momentum is losing steam
●Drifting lower — down 8.1% over the last 5 days
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Low P/S ratio (4.0x)
●Strong revenue growth (+150%)
●Piotroski F-Score strong (8/9, low-confidence approx)

IDX Signals

●Drifting lower — down 3.7% over the last 5 days
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (1.0x)
●Strong revenue growth (+56%)
●EPS estimates revised upward (+10pts)
●Near 52-week low (13% of range)
●New substantial holder(s) (1)

Ask Scout AI to compare BLS and IDX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

BLS vs LGP →BLS vs LTP →BLS vs MYX →BLS vs NSB →BLS vs NXN →
BLS Full Analysis → IDX Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).